CLEVELAND, Ohio— The Cleveland biotech start-up Asclepii, founded in a college dorm room, is seeking to change lives for ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

On May 1, Weave Communications reported significant quarterly growth with expanded AI adoption, Illumina delivered above-guidance results alongside new product launches, and the University of Iowa ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

After launching in 2025 as a refuge for shipwrecked assets from Galapagos, Onco3R Therapeutics is rebranding as Coultreon ...

After Xoma Royalty went on a dealmaking spree last year, the biotech royalty aggregator is now itself being bought out by its ...

Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...